TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials

Aim Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial simultaneously, or from starting a second trial too soon after the first. Methods TOPS (The Over-volunteering Prevention System) is internet-b...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical pharmacology Vol. 68; no. 7; pp. 1019 - 1024
Main Authors Boyce, M., Walther, M., Nentwich, H., Kirk, J., Smith, S., Warrington, S.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.07.2012
Springer
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0031-6970
1432-1041
1432-1041
DOI10.1007/s00228-012-1231-8

Cover

Loading…
Abstract Aim Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial simultaneously, or from starting a second trial too soon after the first. Methods TOPS (The Over-volunteering Prevention System) is internet-based, simple and quick to use, free to users and a charity run by a Board of Trustees. Users enter only two or three pieces of information: (1) ‘National Insurance number’ (NINO) of UK citizens, or ‘passport number’ and country of origin of non-UK citizens, as their identifier, (2) ‘date of last dose’ of trial medicine or (3) ‘never dosed’. Subjects must consent, but TOPS collects only non-personal data, so it does not require Ethics Committee approval and is not covered by the Data Protection Act. Results A total of 55 research units (29 clinical research organisations, 5 pharmaceutical companies, 13 universities and 8 hospitals) throughout the UK have registered to use TOPS, and have entered 124,906 volunteers since we launched it. All commercial and many non-commercial units now use TOPS. In our unit, no subject has to the best of our knowledge participated in two trials simultaneously. TOPS has reduced to <1% the incidence of subjects attempting to volunteer within 3 months of completing another trial elsewhere, and very few have to our knowledge succeeded. Conclusion TOPS is widely used and effective, and helps research units to comply with UK clinical trial regulations.
AbstractList Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial simultaneously, or from starting a second trial too soon after the first. TOPS (The Over-volunteering Prevention System) is internet-based, simple and quick to use, free to users and a charity run by a Board of Trustees. Users enter only two or three pieces of information: (1) 'National Insurance number' (NINO) of UK citizens, or 'passport number' and country of origin of non-UK citizens, as their identifier, (2) 'date of last dose' of trial medicine or (3) 'never dosed'. Subjects must consent, but TOPS collects only non-personal data, so it does not require Ethics Committee approval and is not covered by the Data Protection Act. A total of 55 research units (29 clinical research organisations, 5 pharmaceutical companies, 13 universities and 8 hospitals) throughout the UK have registered to use TOPS, and have entered 124,906 volunteers since we launched it. All commercial and many non-commercial units now use TOPS. In our unit, no subject has to the best of our knowledge participated in two trials simultaneously. TOPS has reduced to <1% the incidence of subjects attempting to volunteer within 3 months of completing another trial elsewhere, and very few have to our knowledge succeeded. TOPS is widely used and effective, and helps research units to comply with UK clinical trial regulations.
Aim Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial simultaneously, or from starting a second trial too soon after the first. Methods TOPS (The Over-volunteering Prevention System) is internet-based, simple and quick to use, free to users and a charity run by a Board of Trustees. Users enter only two or three pieces of information: (1) ‘National Insurance number’ (NINO) of UK citizens, or ‘passport number’ and country of origin of non-UK citizens, as their identifier, (2) ‘date of last dose’ of trial medicine or (3) ‘never dosed’. Subjects must consent, but TOPS collects only non-personal data, so it does not require Ethics Committee approval and is not covered by the Data Protection Act. Results A total of 55 research units (29 clinical research organisations, 5 pharmaceutical companies, 13 universities and 8 hospitals) throughout the UK have registered to use TOPS, and have entered 124,906 volunteers since we launched it. All commercial and many non-commercial units now use TOPS. In our unit, no subject has to the best of our knowledge participated in two trials simultaneously. TOPS has reduced to <1% the incidence of subjects attempting to volunteer within 3 months of completing another trial elsewhere, and very few have to our knowledge succeeded. Conclusion TOPS is widely used and effective, and helps research units to comply with UK clinical trial regulations.
Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial simultaneously, or from starting a second trial too soon after the first. TOPS (The Over-volunteering Prevention System) is internet-based, simple and quick to use, free to users and a charity run by a Board of Trustees. Users enter only two or three pieces of information: (1) 'National Insurance number' (NINO) of UK citizens, or 'passport number' and country of origin of non-UK citizens, as their identifier, (2) 'date of last dose' of trial medicine or (3) 'never dosed'. Subjects must consent, but TOPS collects only non-personal data, so it does not require Ethics Committee approval and is not covered by the Data Protection Act. A total of 55 research units (29 clinical research organizations, 5 pharmaceutical companies, 13 universities and 8 hospitals) throughout the UK have registered to use TOPS, and have entered 124,906 volunteers since we launched it. All commercial and many non-commercial units now use TOPS. In our unit, no subject has to the best of our knowledge participated in two trials simultaneously. TOPS has reduced to <1% the incidence of subjects attempting to volunteer within 3 months of completing another trial elsewhere, and very few have to our knowledge succeeded. TOPS is widely used and effective, and helps research units to comply with UK clinical trial regulations.[PUBLICATION ABSTRACT]
Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial simultaneously, or from starting a second trial too soon after the first.AIMOur aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial simultaneously, or from starting a second trial too soon after the first.TOPS (The Over-volunteering Prevention System) is internet-based, simple and quick to use, free to users and a charity run by a Board of Trustees. Users enter only two or three pieces of information: (1) 'National Insurance number' (NINO) of UK citizens, or 'passport number' and country of origin of non-UK citizens, as their identifier, (2) 'date of last dose' of trial medicine or (3) 'never dosed'. Subjects must consent, but TOPS collects only non-personal data, so it does not require Ethics Committee approval and is not covered by the Data Protection Act.METHODSTOPS (The Over-volunteering Prevention System) is internet-based, simple and quick to use, free to users and a charity run by a Board of Trustees. Users enter only two or three pieces of information: (1) 'National Insurance number' (NINO) of UK citizens, or 'passport number' and country of origin of non-UK citizens, as their identifier, (2) 'date of last dose' of trial medicine or (3) 'never dosed'. Subjects must consent, but TOPS collects only non-personal data, so it does not require Ethics Committee approval and is not covered by the Data Protection Act.A total of 55 research units (29 clinical research organisations, 5 pharmaceutical companies, 13 universities and 8 hospitals) throughout the UK have registered to use TOPS, and have entered 124,906 volunteers since we launched it. All commercial and many non-commercial units now use TOPS. In our unit, no subject has to the best of our knowledge participated in two trials simultaneously. TOPS has reduced to <1% the incidence of subjects attempting to volunteer within 3 months of completing another trial elsewhere, and very few have to our knowledge succeeded.RESULTSA total of 55 research units (29 clinical research organisations, 5 pharmaceutical companies, 13 universities and 8 hospitals) throughout the UK have registered to use TOPS, and have entered 124,906 volunteers since we launched it. All commercial and many non-commercial units now use TOPS. In our unit, no subject has to the best of our knowledge participated in two trials simultaneously. TOPS has reduced to <1% the incidence of subjects attempting to volunteer within 3 months of completing another trial elsewhere, and very few have to our knowledge succeeded.TOPS is widely used and effective, and helps research units to comply with UK clinical trial regulations.CONCLUSIONTOPS is widely used and effective, and helps research units to comply with UK clinical trial regulations.
Author Walther, M.
Kirk, J.
Smith, S.
Nentwich, H.
Warrington, S.
Boyce, M.
Author_xml – sequence: 1
  givenname: M.
  surname: Boyce
  fullname: Boyce, M.
  email: mboyce@hmrlondon.com
  organization: Hammersmith Medicines Research (HMR)
– sequence: 2
  givenname: M.
  surname: Walther
  fullname: Walther, M.
  organization: Hammersmith Medicines Research (HMR)
– sequence: 3
  givenname: H.
  surname: Nentwich
  fullname: Nentwich, H.
  organization: Hammersmith Medicines Research (HMR)
– sequence: 4
  givenname: J.
  surname: Kirk
  fullname: Kirk, J.
  organization: Hammersmith Medicines Research (HMR)
– sequence: 5
  givenname: S.
  surname: Smith
  fullname: Smith, S.
  organization: Hammersmith Medicines Research (HMR)
– sequence: 6
  givenname: S.
  surname: Warrington
  fullname: Warrington, S.
  organization: Hammersmith Medicines Research (HMR)
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26017026$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22349161$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9rFDEQx4NU7LX6B_giARF8WTtJ9qcPBSlqhUIF63PIZmd7ObLJmWQP7r835121LdiXDEk-329mMnNCjpx3SMhrBh8YQHMWAThvC2C8YFywon1GFqwUeQclOyILgHxYdw0ck5MYVwCs6kC8IMeci7JjNVsQvLn-_uMjVY4alzA4TEWvIg40bmPCiSZP1wE36BJdorJpuaVx7leoU6Rj8BP1GwzFxts5yzEYd0tHH6i2xhmtLE3BKBtfkudjDvjqEE_Jzy-fby4ui6vrr98uPl0VugJIxdAKDnpUvNa9qvTYleUoUFUwNEOrq7bSTTtwxcah1201NIjQIeNKawDodSlOyfnedz33Ew46px2UletgJhW20isjH944s5S3fiOFaEoGXTZ4fzAI_teMMcnJRI3WKod-jpIBh4pxaEVG3z5CV34OLpf3h4IyLyxTb-5n9DeVuw5k4N0BUDF_2BiU0yb-42pgDfA6c82e08HHGHCU2iSVjN8VYmx-U-5mQu5nQuaZkLuZkG1WskfKO_OnNHyvietdTzHcL-5_ot8vJsnh
CitedBy_id crossref_primary_10_12688_wellcomeopenres_14668_1
crossref_primary_10_33920_MED_12_2402_02
crossref_primary_10_1016_j_ebiom_2018_07_035
crossref_primary_10_33920_MED_12_2402_01
crossref_primary_10_33920_MED_12_2403_02
crossref_primary_10_1007_s00228_017_2329_9
crossref_primary_10_1007_s00228_013_1534_4
crossref_primary_10_12688_wellcomeopenres_14668_2
crossref_primary_10_1007_s00228_012_1349_8
crossref_primary_10_1016_j_trsl_2016_05_006
Cites_doi 10.1023/A:1012365806338
10.1046/j.1365-2125.2003.01923.x
10.1016/S1765-4629(04)94650-8
ContentType Journal Article
Copyright The Author(s) 2012
2015 INIST-CNRS
Springer-Verlag 2012
Copyright_xml – notice: The Author(s) 2012
– notice: 2015 INIST-CNRS
– notice: Springer-Verlag 2012
DBID C6C
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TK
7U9
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1007/s00228-012-1231-8
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Neurosciences Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest One Academic Middle East (New)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Open Access资源_Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-1041
EndPage 1024
ExternalDocumentID PMC3374109
2685223211
22349161
26017026
10_1007_s00228_012_1231_8
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom--UK
GeographicLocations_xml – name: United Kingdom--UK
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8FW
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYOK
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADOJX
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADYPR
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
ECT
EIHBH
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
MK0
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
WOW
Y6R
YLTOR
Z45
Z7U
Z7V
Z7W
Z81
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8U
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U9
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c500t-d8320cfa26cba5cf944f3ea50d7d8c585c78d2a1fdbc85d7ee09e12acc000bc43
IEDL.DBID U2A
ISSN 0031-6970
1432-1041
IngestDate Thu Aug 21 18:28:24 EDT 2025
Fri Jul 11 01:28:43 EDT 2025
Fri Jul 25 04:40:39 EDT 2025
Wed Feb 19 01:55:14 EST 2025
Mon Jul 21 09:10:46 EDT 2025
Tue Jul 01 01:41:09 EDT 2025
Thu Apr 24 23:10:08 EDT 2025
Fri Feb 21 02:34:21 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords TOPS
Healthy volunteers
Over-volunteering
Phase 1 trials
Human
Prevention
Healthy subject
Phase I trial
Clinical trial
Internet
Language English
License CC BY 4.0
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c500t-d8320cfa26cba5cf944f3ea50d7d8c585c78d2a1fdbc85d7ee09e12acc000bc43
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://link.springer.com/10.1007/s00228-012-1231-8
PMID 22349161
PQID 1020040201
PQPubID 47171
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3374109
proquest_miscellaneous_1020512083
proquest_journals_1020040201
pubmed_primary_22349161
pascalfrancis_primary_26017026
crossref_citationtrail_10_1007_s00228_012_1231_8
crossref_primary_10_1007_s00228_012_1231_8
springer_journals_10_1007_s00228_012_1231_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-07-01
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 07
  year: 2012
  text: 2012-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Heidelberg
– name: Germany
PublicationTitle European journal of clinical pharmacology
PublicationTitleAbbrev Eur J Clin Pharmacol
PublicationTitleAlternate Eur J Clin Pharmacol
PublicationYear 2012
Publisher Springer-Verlag
Springer
Springer Nature B.V
Publisher_xml – name: Springer-Verlag
– name: Springer
– name: Springer Nature B.V
References CR2
CR3
CR5
Daugman (CR6) 2001; 45
CR8
CR7
CR18
(CR1) 1986; 20
CR17
CR9
CR16
CR15
Boyce, Nentwich, Melbourne, Warrington (CR4) 2003; 55
CR14
CR13
CR12
CR11
CR10
1231_CR11
1231_CR10
M Boyce (1231_CR4) 2003; 55
1231_CR5
1231_CR3
1231_CR2
1231_CR1
1231_CR13
1231_CR12
1231_CR15
1231_CR14
1231_CR17
J Daugman (1231_CR6) 2001; 45
1231_CR9
1231_CR16
1231_CR8
1231_CR7
1231_CR18
22843015 - Eur J Clin Pharmacol. 2013 Mar;69(3):729
22968810 - Eur J Clin Pharmacol. 2013 Mar;69(3):731
11643937 - J R Coll Physicians Lond. 1986 Oct;20(4):3-17
References_xml – ident: CR18
– ident: CR3
– ident: CR14
– ident: CR15
– ident: CR2
– ident: CR16
– ident: CR12
– ident: CR17
– volume: 20
  start-page: 3
  year: 1986
  end-page: 17
  ident: CR1
  article-title: Research on healthy volunteers. A report of the Royal College of Physicians
  publication-title: J R Coll Physicians
– ident: CR13
– ident: CR10
– ident: CR11
– ident: CR9
– ident: CR5
– ident: CR7
– ident: CR8
– volume: 45
  start-page: 25
  year: 2001
  end-page: 38
  ident: CR6
  article-title: Statistical richness of visual phase information: update on recognizing persons by their iris patterns
  publication-title: Int J Comput Vis
  doi: 10.1023/A:1012365806338
– volume: 55
  start-page: 643P
  year: 2003
  ident: CR4
  article-title: TOPS: the over-volunteering prevention system
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.2003.01923.x
– ident: 1231_CR5
– ident: 1231_CR8
– ident: 1231_CR7
– ident: 1231_CR9
– ident: 1231_CR1
– ident: 1231_CR2
– ident: 1231_CR18
– volume: 55
  start-page: 643P
  year: 2003
  ident: 1231_CR4
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.2003.01923.x
– ident: 1231_CR3
– ident: 1231_CR13
– ident: 1231_CR16
– ident: 1231_CR10
– ident: 1231_CR11
– ident: 1231_CR14
  doi: 10.1016/S1765-4629(04)94650-8
– ident: 1231_CR12
– ident: 1231_CR17
– ident: 1231_CR15
– volume: 45
  start-page: 25
  year: 2001
  ident: 1231_CR6
  publication-title: Int J Comput Vis
  doi: 10.1023/A:1012365806338
– reference: 22843015 - Eur J Clin Pharmacol. 2013 Mar;69(3):729
– reference: 22968810 - Eur J Clin Pharmacol. 2013 Mar;69(3):731
– reference: 11643937 - J R Coll Physicians Lond. 1986 Oct;20(4):3-17
SSID ssj0015903
Score 2.0392566
Snippet Aim Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial...
Our aim was to set up a system to help UK clinical research units to prevent healthy volunteers from participating in more than one non-therapeutic trial...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1019
SubjectTerms Biological and medical sciences
Biomedical and Life Sciences
Biomedical Research - ethics
Biomedical Research - legislation & jurisprudence
Biomedical Research - organization & administration
Biomedicine
Clinical Trial
Clinical trials
Clinical Trials as Topic - ethics
Clinical Trials as Topic - legislation & jurisprudence
Clinical Trials as Topic - standards
Government Regulation
Humans
Internet
Medical sciences
Nontherapeutic Human Experimentation - ethics
Nontherapeutic Human Experimentation - legislation & jurisprudence
Nontherapeutic Human Experimentation - standards
Participation
Pharmacology. Drug treatments
Pharmacology/Toxicology
Regulation
Research Subjects - legislation & jurisprudence
United Kingdom
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7a9FIooW36cJoGFUIObQSyZa_tXkoJDSGQZqEb2JuR9SCB4t3W3sP--85ItjfbNrnsRZJZe16fpJlvAI5sktYS4xqXSic8tTLjtXXoDK2qtYltpg3VO19-n5xfpxfzbN4fuLV9WuXgE72jNgtNZ-Ro3SRP_Im_LH9x6hpFt6t9C43H8ISoyyilK5-PGy6M1KIn3Y35pMzHW03hSUQT4maOqbUHDhdbcenZUrX4iVzobfE_8PlvDuVfF6k-Pp09h90eWLKvQRNewCPbvITjaWCmXp-w2abQqj1hx2y64axe74GdXU1_fGaqYbf-iNB2nOKbYYHpmXULtgxkTyxUTq5Zu6rpDKdlVKHCKBOUk6vD5Z7dkCEaZkPdJfPNQdpXcH32bXZ6zvsODFxnQnTcoL0L7VQy0bXKtCvT1EmrMmFyU2jcaei8MImKnal1kZncWlHaOFFao6etdSpfw06zaOxbYKnLLYJPk5WmoI7XhZIO93rOIgTBB7oIxPD9K93Tk1OXjJ_VSKzsRVahyCoSWVVE8HFcsgzcHA9NPtwS6riCONVy3IlGcDBIuertuK02WhfBh3EYLZCuVVRjF6swB2ETYtkI3gSl2Dw8kSkCcFydb6nLOIHYvbdHmtsbz_ItJYI9UUbwaVCsu3_rnrfcf_gl3sHThFTepxsfwE73e2XfI6jq6kNvOX8AXsUgZg
  priority: 102
  providerName: ProQuest
Title TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials
URI https://link.springer.com/article/10.1007/s00228-012-1231-8
https://www.ncbi.nlm.nih.gov/pubmed/22349161
https://www.proquest.com/docview/1020040201
https://www.proquest.com/docview/1020512083
https://pubmed.ncbi.nlm.nih.gov/PMC3374109
Volume 68
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_W9mUwRvdZt13QYPRhq8C2rMjeWxbSlY11YUsgezKyPlhhOGF2HvLf9yR_pOm6wV5ssCVh-3Sn3_l0vwN4Y-KkYLiuUSZVTBPDOC2MRWNoZKF0ZLjSLt_5y9Xwcp58WvBFm8dddbvdu5Ckt9R9spunakHX1xXjYBFN9-CAO9cdJ_E8HvWhA56FLdNuRIeZ6EOZ9w2xsxg9WskKv4ttClrchzj_3Dh5J3rqF6WLQ3jcokkyasT_BB6Y8imcTRs66s05mW2zq6pzckamW6LqzTMws6_T7--JLMm1_y9oauoWNU0aemdSL8mqYXgiTbrkhlTrwv24qYhLSyFu-yd19g27e0pDghCYdMmWxFcEqZ7D_GIyG1_StuwCVTwMa6pRyUNlZTxUheTKZklimZE81EKnCt0LJVIdy8jqQqVcC2PCzESxVArNa6ES9gL2y2VpjoAkVhhEnJpnOnVlrlPJLDp41iDuwAFtAGH3_XPVcpK70hi_8p5N2YssR5HlTmR5GsDbvsuqIeT4V-PBjlD7Ho5ITaD7GcBpJ-W8Vd4Kx3KmAw9RAK_726h2LpYiS7NcN20QKyGADeBlMym2g8csQdSNvcXOdOkbOErv3Tvl9U9P7c0YIrwwC-BdN7FuP9Zf3vL4v1qfwMPYaYDfcnwK-_XvtXmFwKouBrAnFmIAB6OPPz5P8PxhcjX9hlfHw_HAK9kNnAQh_w
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEkhHgTKMVI0APUUmInmwQJIR6ttrRdVrCVeguO7YhKKLuQrND-KX4jM3GSZXn01ksu9lhJZjz-7PF8A_DEijCXuK5xqbTgoZURz22BztCqXJvARtpQvvPxeDg6Cd-fRqcb8LPLhaFrlZ1PbBy1mWk6I8fZTfrER_Bq_o1T1SiKrnYlNJxZHNrlD9yyVS8P3qF-nwqxvzd9O-JtVQGuI9-vuUEb9nWhxFDnKtJFGoaFtCryTWwSjehZx4kRKihMrpPIxNb6qQ2E0hq9R65DieNegs1Q4lZmAJtv9saTj33cIkr9luY34MM07uOofkNbKogNOqBiIticrK2EV-eqQqUUrprGv-Du37c2_wjdNivi_nW41kJZ9trZ3g3YsOVN2Jk4LuzlLpuuUruqXbbDJiuW7OUtsNMPk08vmCrZWXMoaWtOK6phjlua1TM2d_RSzOVqLlm1yOnUqGKUE8Po7ikn54riDZ8iQ_zNukxP1pQjqW7DyYVo5w4Myllp7wELi9gi3DVRahKqsZ0oWeDusrAIenDAwgO_-_-ZbgnRqS7H16yncm5UlqHKMlJZlnjwrBeZOzaQ8zpvrym1lyAWtxj3vh5sdVrOWs9RZSs79-Bx34xzngI5qrSzheuDQA3Rswd3nVGsBhcyRMiP0vGaufQdiE98vaU8-9LwikuJ8NJPPXjeGdbvr_Wfr7x__kc8gsuj6fFRdnQwPnwAVwSZf3PZeQsG9feFfYiQrs6323nE4PNFT91fL7pg2w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD7UCiIU8W601hG0D9rBZCbZZAURsS6t1brgFvYtTuZCC5JdTRbZv-av85xMknW99K0veZkLSc5lvpk55zsAT6yIC4nrGpdKCx5bmfDCOnSGVhXaRDbRhvKdPx4PDk7i99NkugE_u1wYCqvsfGLjqM1M0xk5WjfJEx_RC9eGRYz3R6_n3zhVkKKb1q6chleRI7v8gdu36tXhPsr6qRCjd5O3B7ytMMB1EoY1N6jPoXZKDHShEu2GceykVUloUpNpRNI6zYxQkTOFzhKTWhsObSSU1uhJCh1LnPcSXE5lEpGNpdN-s4coIWwJfyM-GKb9jWrYEJgK4oWOqKwINmdra-LWXFUoHufravwL-P4dv_nHJW6zNo6uw7UW1LI3XgtvwIYtb8Lu2LNiL_fYZJXkVe2xXTZe8WUvb4GdfBp_fslUyc6a40lbc1pbDfMs06yesbknmmI-a3PJqkVB50cVo-wYRlGonNwsDm-YFRkicdblfLKmMEl1G04uRDZ3YLOclfYesNilFoGvSYYmo2rbmZIO95nOIvzBCV0AYff_c91So1OFjq95T-rciCxHkeUksjwL4Fk_ZO55Qc7rvLMm1H4E8bmluAsOYLuTct76kCpfaXwAj_tmtH660lGlnS18H4RsiKMDuOuVYjW5kDGCfxydrqlL34GYxddbyrPThmFcSgSa4TCA551i_f5a__nK--d_xCO4ggabfzg8PnoAVwVpfxP1vA2b9feFfYjYri52GiNi8OWirfYXlhdjqw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TOPS%3A+an+internet-based+system+to+prevent+healthy+subjects+from+over-volunteering+for+clinical+trials&rft.jtitle=European+journal+of+clinical+pharmacology&rft.au=Boyce%2C+M&rft.au=Walther%2C+M&rft.au=Nentwich%2C+H&rft.au=Kirk%2C+J&rft.date=2012-07-01&rft.issn=1432-1041&rft.eissn=1432-1041&rft.volume=68&rft.issue=7&rft.spage=1019&rft_id=info:doi/10.1007%2Fs00228-012-1231-8&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6970&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6970&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6970&client=summon